IPCALAB — Ipca Laboratories Cashflow Statement
0.000.00%
Last trade - 00:00
- IN₹339.70bn
- IN₹363.33bn
- IN₹62.44bn
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 5,465 | 7,389 | 13,813 | 11,357 | 7,453 |
Depreciation | |||||
Non-Cash Items | -38.1 | 308 | -184 | -373 | -264 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -2,328 | -4,156 | -4,819 | -4,707 | -1,747 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 4,923 | 5,646 | 10,901 | 8,602 | 8,058 |
Capital Expenditures | -1,805 | -3,063 | -3,616 | -4,790 | -4,945 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 242 | -2,034 | -1,591 | -3,761 | -2,305 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -1,563 | -5,097 | -5,207 | -8,551 | -7,250 |
Financing Cash Flow Items | 22.4 | -144 | -84.1 | -61.8 | -415 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -1,832 | -1,305 | -3,058 | 4,268 | 5,072 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 1,528 | -755 | 2,636 | 4,319 | 5,881 |